AIDS Rev. 2009 Apr-Jun;11(2):59-70.

The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.

Sendagire H, Easterbrook PJ, Nankya I, Arts E, Thomas D, Reynolds SJ.

Source

Infectious Diseases Institute, Kampala, Uganda. hsendagire@idi.co.ug

Abstract

Antiretroviral therapy programs in Africa are currently providing treatment for almost two million people. The long-term success of large scale antiretroviral therapy programs in sub-Saharan Africa remains uncertain because of the limited information currently available on rates of virologic failure and selection for drug-resistant variants in the different HIV subtypes. This article provides a comprehensive review of the published literature on the prevalence of primary and secondary HIV drug resistance with different subtypes and in various settings across sub-Saharan Africa.

PMID:: 19529746; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Permanyer Publications - PDF

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review HIV antiretroviral drug resistance in Africa. [AIDS Rev. 2004]
Review HIV antiretroviral drug resistance in Africa.
Nkengasong JN, Adje-Toure C, Weidle PJ. AIDS Rev. 2004 Jan-Mar; 6(1):4-12.
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy. [J Acquir Immune Defic Syndr. 2...]
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy.
Geretti AM, Fox ZV, Booth CL, Smith CJ, Phillips AN, Johnson M, Li JF, Heneine W, Johnson JA. J Acquir Immune Defic Syndr. 2009 Dec; 52(5):569-73.
Review The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. [Antivir Ther. 2008]
Review The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, PharmAccess African Studies to Evaluate Resistance Programme. Antivir Ther. 2008; 13(5):625-39.
Review Drug resistance in non-subtype B HIV-1. [J Clin Virol. 2004]
Review Drug resistance in non-subtype B HIV-1.
Kantor R, Katzenstein D. J Clin Virol. 2004 Mar; 29(3):152-9.
Antiretroviral resistance. [J HIV Ther. 2006]
Antiretroviral resistance.
Geretti AM. J HIV Ther. 2006 Dec; 11(4):72-3.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
AIDS Rev. 2009 Apr-Jun ;11(2):59-70.

PubMed
Lichen planus and malignancy. An epidemiologic study of 2071 patients and a revi...
Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature.
Arch Dermatol. 1991 Nov ;127(11):1684-8.

PubMed
Laser-scanning optical-resolution photoacoustic microscopy.
Laser-scanning optical-resolution photoacoustic microscopy.
Opt Lett. 2009 Jun 15 ;34(12):1771-3.

PubMed
Fluorescence coherence tomography.
Fluorescence coherence tomography.
Opt Express. 2006 Aug 7 ;14(16):7134-43.

PubMed
Appetite control and energy balance regulation in the modern world: reward-drive...
Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals.
Int J Obes (Lond). 2009 Jun ;33 Suppl 2:S8-13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: